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1.  Introduction 
 
Methamphetamine is a highly addictive stimulant associated with serious health and 
psychiatric conditions, including heart damage and brain damage, impaired thinking and 
memory problems, aggression, violence, and psychotic behavior. Methamphetamine is also 
associated with the transmission of infectious diseases such as HIV/AIDS and hepatitis.  
 
Child welfare workers are seeing growing numbers of children and families affected by the 
parent’s use of methamphetamine. In order to make sound decisions for the benefit of 
children and families, child welfare workers need accurate information about 
methamphetamine, its effects on parents and their children, and the effectiveness of 
treatment. This paper presents the most current research in these areas, and offers 
recommendations for child welfare workers to help them identify and assist children and 
families affected by a parent’s use of methamphetamine.  
 
 
2.  Patterns of Methamphetamine Use 
 
In 2004, an estimated 1.4 million persons (0.6 percent aged 12 or older) had used 
methamphetamine in the past year, 583,000 (0.2 percent) had used in the past month, and 
an estimated 318,000 used methamphetamine for the first time in the past year.1 Between 
2002 and 2004, the number of methamphetamine users and the number of new 
methamphetamine users remained relatively stable. During the same 2002 to 2004 time 
period, the number of past month methamphetamine users who met the Diagnostic and 
Statistical Manual (DSM IV) criteria for substance abuse or dependence in the past year 
increased from an estimated 164,000 (27.5 percent of past month methamphetamine 
users) in 2002 to 346,000 (59.3 percent) in 2004.2 
 
To provide a perspective on methamphetamine use, it is helpful to compare 
methamphetamine users with the users of cocaine, another stimulant that has been a child 
welfare issue for the past two decades. Compared with cocaine users, methamphetamine 
users exhibit the following characteristics3,4,5: 
 
• begin using substances at a younger age 
 
• enter treatment at a younger age 
 
• are more likely to use multiple drugs (especially marijuana) 
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• have a higher frequency of use 
 
• are less likely to use alcohol 
 
• report feeling less “addicted” than cocaine users 
 
• are more likely to use methamphetamine continuously throughout the day at evenly 
spaced intervals and consistently over time, rather than concentrating use in the 
evening as cocaine users tend to do  
 
• use fewer times per day than cocaine users (though the same amount of drug is used) 
 
• spend less money to purchase the drug  
 
• are more likely to be female and Caucasian  
 
Of the total number of individuals admitted to treatment in 2003 for methamphetamine, 
45% are women. This percentage of female admissions is higher than the percentage of 
female admissions associated with any other drugs except tranquilizers, sedatives and other 
opiates (i.e. non-prescription use of methadone, codeine, morphine, oxycodone, 
hydromorphone, meperidine, opium, and other drugs with morphine-like effects).6 The 
implication is that more children are likely to be affected by a parent’s use of 
methamphetamine since caretakers are often predominately female. 
 
Compared with male methamphetamine users, female methamphetamine users7,8:  
 
• use methamphetamine more days in a 30-day period  
 
• smoke rather than snort or inject the drug  
 
• are more likely to be single parents who live alone with their children  
 
• have worse medical, psychiatric, and employment profiles  
 
These statistics indicate a greater risk for the children of mothers who use 
methamphetamine. The parent is likely to use the drug more often and have greater 
difficulty providing adequate parenting and economic support for the child. 
 
Methamphetamine users, like other drug users, are more likely than non-users to have 
experienced physical or sexual abuse as children. A recent study found that 33% of 
methamphetamine users had been sexually abused before the age of 15 and a similar 
percentage reported childhood physical abuse.9  
 
There is a well-documented relationship between substance abuse and child abuse and 
neglect.10,11,12,13 Those who have been abused or neglected as children are more likely to 
have substance use disorders as adults, and adults with substance use disorders are more 
likely to abuse or neglect their own children. The result is a multigenerational cycle of 
substance abuse and child abuse and neglect. For this reason, effective intervention by child 
welfare becomes crucial, and comprehensive, integrated services are needed to break the 
cycle of abuse and addiction.   
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3.  Effects of Methamphetamine Addiction 
 
To understand the physiological and psychological effects of methamphetamine use, it is 
helpful to review the effects of methamphetamine on the brain. 
 
Methamphetamine appears to cause long-term structural damage to the regions of the brain 
that control memory and motor coordination. These effects may be related to the length of 
time that methamphetamine remains in the user’s system.14 Compared to cocaine and other 
drugs, methamphetamine remains active in the body much longer, and a greater 
percentage of the drug remains unchanged in the body.15 Smoking cocaine produces a high 
that lasts 20-30 minutes, while smoking methamphetamine produces a high that lasts 8-24 
hours. It takes one hour for 50% of a specified amount of cocaine to be removed from the 
body, while it takes twelve hours for 50% of the same amount of methamphetamine to be 
removed. For these reasons, methamphetamine remains in the brain longer, producing 
prolonged stimulant effects that may permanently damage blood vessels in the brain.16 
Methamphetamine use produces abnormal brain chemistry in all areas of the brain, and 
users with the greatest cumulative lifetime use have the strongest indications of cell 
damage.17 
 
A significant effect of methamphetamine use is the loss of dopamine transporters in the 
brain.18,19,20,21 Dopamine is a brain chemical that facilitates critical brain functions. 
Methamphetamine triggers the release of large amounts of dopamine in areas of the brain 
that regulate feelings of pleasure and body movement.22 Dopamine transporters are 
structures on the neurons that clear dopamine from the space between neurons. Earlier 
studies speculated that the loss of dopamine transporters represented irreversible 
degeneration in the brain.23 However, Volkow and colleagues24 found that the number of 
dopamine transporters increased significantly after 12 and 17 months of abstinence. Their 
study also found that motor skills and memory did not improve at the same rate that 
dopamine transporters increased, within the 12- and 17-month periods of abstinence. 
However, in a study involving longer periods of abstinence, Lundahl and colleagues25 found 
no deficits in motor function, memory, learning, attention, or executive function in 
methamphetamine users after four years of abstinence.   
 
Methamphetamine use does cause brain damage, but protracted abstinence appears to 
reverse at least some of that damage. The degree of recovery is related to the length of 
time that the methamphetamine user remains abstinent.26,27   
 
Cognitive Deficits 
 
The observable effects of methamphetamine use include cognitive deficits, health problems, 
and psychological problems. The cognitive deficits are discussed below, and the health and 
psychological effects are discussed in the next section. 
 
Studies have found that methamphetamine users exhibit cognitive impairment. Active 
methamphetamine users are impaired in their ability to learn, recall, make inferences, 
manipulate information, and ignore irrelevant information.28 Some of these cognitive 
deficits, including deficits in the ability to manipulate information and ignore irrelevant 
information were no longer present after 12 weeks of abstinence. The abstinent 
methamphetamine user regained the ability to manipulate information and to ignore 
irrelevant information. Other deficits, such as the ability to recognize and recall word 
became worse in this initial phase of abstinence. The deficit in picture recognition also 
became worse, but to a lesser degree than did the deficit in word recognition and recall.29  
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Research also shows that exposure to stimulant drugs such as methamphetamine can 
impair the ability of specific brain cells to change as a result of experience. Thus, the ability 
to learn from experience may be diminished by the use of stimulant drugs.30  
 
These cognitive impairments become significant when child welfare workers work with 
parents who are using methamphetamine or are in the first few months of abstinence. 
These parents may find it difficult to pay attention, to comprehend spoken or written 
information, and to retain information. Because the ability to recognize pictures is less 
impaired than the ability to recognize words, treatment providers have begun using visual 
cues, such as handouts with pictures when working with these clients.31 Child welfare 
workers can use this strategy to provide information to parents in a way they can more 
easily comprehend and retain.   
 
Health Effects and Psychological Effects 
 
Methamphetamine use is associated with serious health problems, including cardiovascular 
problems and HIV risk behavior.32,33 Side effects include rapid and irregular heartbeat, 
increased blood pressure, hyperthermia, convulsions, stroke, insomnia, restlessness, and 
tremors34,35,36. After prolonged use, methamphetamine users may exhibit nosebleeds, 
itching, skin welts and lesions, and infected injection sites.37 They may also experience 
nausea, vomiting, and diarrhea. Weight loss and malnutrition are common, due to the 
decrease in appetite caused by the drug. Users may have significant dental problems, 
including gum disease and tooth loss, after long-term use.38 Dental problems result from a 
combination of factors, including the reduction in saliva caused by methamphetamine, poor 
dental hygiene, and poor nutrition due to decreased appetite.  
 
Methamphetamine use is also associated with a variety of psychological problems. 
Methamphetamine users appear to be more psychologically disturbed, to have more 
psychological problems, and to be more out of control than other substance abusers.39  
Chronic methamphetamine use can lead to psychotic behavior, including intense paranoia, 
confusion, visual and auditory hallucinations, and violent behavior.40,41 Psychotic symptoms 
can sometimes persist for months or years after use has stopped.42,43  
 
Individuals who stop using methamphetamine may experience depression and anxiety. In 
the 12 months following treatment, methamphetamine users were more likely to have 
psychiatric difficulties, legal difficulties, family problems, and dissatisfaction with their lives 
than other substance users.44  Even at two to five years after treatment, the rate of 
headaches and depression reported by former methamphetamine users was similar to the 
rate they reported at admission to treatment.45 A recent study of methamphetamine users 
found higher levels of glucose (indicating greater activity) in brain regions linked to anxiety 
and drug cravings, compared to the levels found in non-abusers.46 It is unclear whether 
these findings are specific to methamphetamine addiction, or may apply to other stimulant 
users as well.  
 
It is critical that child welfare workers recognize the implications of the health and 
psychological effects of methamphetamine use. These effects can seriously interfere with a 
parent’s ability to comply with case plan requirements. Primary health care and mental 
health treatment may need to be included in the case plan, and parents may need 
continued support in accessing and receiving those services. 
 
 
4.  Effects of Parental Methamphetamine Use on Children 
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Situations in which children are affected by their parent’s involvement in methamphetamine 
include:  
 
• The parent uses or abuses methamphetamine (episodic use) 
• The parent is chemically dependent on methamphetamine 
• The mother uses methamphetamine while pregnant with the child 
• The parent “cooks” small quantities of methamphetamine in the home  
• The parent sells, transports, or distributes methamphetamine (traffickers) 
• The parent manufactures large quantities of methamphetamine (superlabs)47 
 
Each situation presents specific risks and dangers for the child and specific concerns for the 
child welfare worker. Each separate situation is discussed below.  
 
Parents Who Use or Abuse Methamphetamine 
 
In 2004, an estimated 418,000 (0.2 percent aged 18 or older) had used methamphetamine 
in the past month.48 Given the number of adults who currently use methamphetamine, 
episodic parental use or abuse of methamphetamine is the most common means by which 
children are affected by parental methamphetamine use. This method of exposure accounts 
for the highest number of children exposed to methamphetamine, compared to the numbers 
found in the other categories.49 
 
Parents under the influence of stimulants, including methamphetamine, pose a danger their 
children. When high, the parent may exhibit poor judgment, confusion, irritability, paranoia, 
and increased violence; they may fail to provide adequate supervision. The family and social 
environment may be poor, and the children may be at risk of abuse and neglect due to the 
family dynamics associated with substance use.50  
 
In households where a family member smokes the substance, children may be exposed to 
secondhand methamphetamine smoke. They may accidentally ingest the substance if it is 
kept in the home. 
 
Because methamphetamine users typically use other substances at the same time, including 
alcohol, tobacco, and other drugs, the risks to their children accumulate, and it becomes 
difficult to attribute a particular effect to a particular substance. 
 
Parents with Methamphetamine Dependence 
 
When the parent is dependent on methamphetamine, chronic neglect of the children 
becomes more likely, and the family and social environment is more likely to be inadequate. 
The children are exposed to the drug-affected parent more frequently and for longer periods 
of time. They may be found living in poor conditions, lacking food, water, gas, and 
electricity. They may lack medical care, dental care, and immunizations. These children are 
also at greater risk of abuse.51 
 
Prenatal Exposure 
 
Pregnant methamphetamine users appear to know less about the potential harm to 
themselves or the fetus, compared to users of crack cocaine or heroin.52 Crack cocaine 
users were more likely than the other two groups to fear the negative effects of their drug 
use on their fetus. Heroin-using women were concerned about the effects of their drug use, 
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three groups tended to avoid prenatal care clinics.53  
 
Since the crack epidemic of the late 1980’s, researchers have been aware that prenatal 
stimulant exposure has both direct and indirect effects.54 The fetus is directly affected by 
the cocaine that enters its system, and it is indirectly affected by the decrease in the 
mother’s blood flow that results from cocaine use. Many of the effects of prenatal exposure 
to methamphetamine have also been documented among infants exposed to other 
substances, particularly cocaine/crack.55 Many studies of the effects of prenatal exposure 
however compare methamphetamine-exposed infants to non-exposed infants without also 
comparing them to cocaine-exposed or other stimulant-exposed infants, so it is not known 
whether the effects are associated with methamphetamine in particular or with all 
stimulants.  
 
Stimulant-exposed children may also be affected by other substances used by the mother, 
and by environmental risk factors such as the mother’s nutritional and health status. Recent 
surveys indicate that 12-14% of all pregnant women consume alcohol56 and two-thirds of 
female smokers continue to smoke during pregnancy.57  Among meth using pregnant 
women58, nicotine use is nearly universal while marijuana and alcohol were secondary drugs 
used by 60% of the women. The cumulative effects of the use of multiple substances and 
other environmental risk factors have significant adverse effects on the newborn. These 
effects may be greater than the effects of stimulant use alone.59 Prenatal substance 
exposure can cause birth defects, fetal death, growth retardation, premature birth, low birth 
weight, developmental disorders, difficulty sucking and swallowing, and hypersensitivity to 
touch after birth.60,61,62  
 
Methamphetamine exposure during pregnancy can jeopardize the development of the fetal 
brain and other organs. An echoencephalographic study of neonates who were exposed 
prenatally to methamphetamine or cocaine indicated higher rates of bleeding, decay, and 
lesions in the brain.63 A high dose of methamphetamine taken during pregnancy can cause a 
rapid rise in temperature and blood pressure in the brain of the fetus, which can lead to 
stroke or brain hemorrhage. Infants prenatally exposed to methamphetamine are 
significantly smaller for their gestational age compared with unexposed infants64, and 
methamphetamine-exposed infants whose mothers also smoked tobacco had significantly 
decreased growth, compared with infants exposed to methamphetamine alone.65   
 
Earlier studies of infants prenatally exposed to cocaine, methamphetamine, or both revealed 
no significant differences in perinatal variables among the three drug-exposed groups.66 All 
three groups had altered neonatal behavioral patterns, characterized by abnormal sleep 
patterns, poor feeding, tremors, and hypertonia (excessive muscle tension). All three 
groups also had significantly higher rates of prematurity and intrauterine growth 
retardation, and had smaller head circumferences, compared to the drug-free comparison 
group.67 Infants exposed prenatally to methamphetamine are more likely than other 
prenatally exposed infants to experience feeding problems due to difficulty in sucking and 
swallowing. Shah68 found that 34.4% of methamphetamine exposed infants had feeding 
problems compared to 9.4% of infants prenatally exposed to cocaine. These difficulties 
suggest that infants prenatally exposed to methamphetamine may be at risk for failure to 
thrive issues. 
 
Longer-term effects of prenatal methamphetamine exposure may be similar to other 
substances: long-term cognitive deficits, learning disabilities, and poor social adjustment in 
older children.69,70 Over-stimulation and self-regulation difficulties have been observed with 
cocaine-exposed children71, and these effects may be seen in children exposed to other 
DRAFT PAPER 4-17-06 8
stimulants. A study showed alterations of brain chemistry in children that may be related to 
findings that some cocaine-exposed children are more impulsive and easily distracted than 
their non-exposed peers.72 Additional research is needed to determine if the same effects 
are found in methamphetamine-exposed children. Shah73 describes the symptoms of 
prenatal exposure to methamphetamine in children 18 months to 5 years include less 
focused attention, easily distracted, poor anger management, and aggressive outbursts.  
 
For many years child welfare agencies have been working with mothers, their infants and 
the families affected by prenatal stimulant exposure and can draw on those experiences to 
create the programs and services needed to address the needs of families affected by 
prenatal methamphetamine exposure as well. 
 
Home Labs 
 
Some parents produce relatively small quantities of methamphetamine in their homes for 
their own use or small-scale distribution. Children in these homes are subject to the same 
risks noted in the sections on parents who use/abuse and are dependent on the drug, but 
they have additional risks associated with the substances used in the production of 
methamphetamine and the method of production. The children may be exposed to toxic 
chemicals, contaminated food, fumes released during the “cooking” process, and the danger 
of fire or explosion from the manufacturing process.  
 
The risk of toxic exposure for children in homes where methamphetamine is manufactured 
is high. Children are more likely than adults to suffer health effects from exposure to 
chemicals. They have higher metabolic rates; their skeletal systems and nervous systems 
are developing; their skin is not as thick as an adult’s skin, which means they absorb 
chemicals faster; and children tend to put things in their mouths and use touch to explore 
the world. Some fumes or gases are heavier than air, and will sink down to the child’s level, 
increasing their exposure. Children also tend to imitate adult behavior and are vulnerable in 
chaotic and unsafe environments.74 A review by Kolecki75 revealed that pediatric patients 
with methamphetamine poisoning often exhibited rapid heartbeat, agitation, inconsolable 
crying, irritability, and vomiting. 
 
The section on superlabs below includes signs of methamphetamine production and 
symptoms of methamphetamine exposure.  
 
Trafficking 
 
Parents who traffic in methamphetamine by selling, transporting, or distributing it, expose 
their children to an increased risk of violence and abuse associated with drug trafficking. 
There may be weapons in the home. The parent’s associates or customers may carry 
weapons, putting the children at risk for violence. These children are also at increased risk 
of physical and sexual abuse by those who visit the home.76,77,78,79 
 
Superlabs 
 
Superlabs are methamphetamine laboratories where methamphetamine is produced on a 
large scale. Children are sometimes found in these superlabs, but they are less likely to be 
present in superlabs than in the homes where smaller quantities are produced. From 2000 
to 2003, there were 7,513 known cases of children present at seized methamphetamine 
laboratory sites nationwide, with only 2,881 taken into protective custody.80  During the 
same time frame, almost 1.2 million children were taken into protective custody for all 
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reasons.81 The number of children removed from their parents due to methamphetamine lab 
involvement is an extremely small percentage of the total number of removals. 
 
In 2001, the states reporting the highest number of children present at methamphetamine 
labs were California (503), Washington (326), Oregon (241), and Missouri (161). These 
figures are probably underreported, since many states do not keep records on children 
present at laboratory sites, nor do they medically evaluate the children for the presence of 
drugs or chemicals.  
 
Children in methamphetamine labs are exposed to great risk. They are exposed to the 
chemicals used in the production of methamphetamine. They may be at increased risk for 
severe neglect, and may be physically or sexually abused by family members or others who 
frequent the lab.82,83 They are exposed to the toxic effects of methamphetamine 
manufacturing such as fire explosions, toxic gas, and toxic waste. A child can also be 
harmed by consuming a chemical from a container or ingesting methamphetamine.84 
 
Child welfare workers should be aware of the symptoms of methamphetamine exposure so 
that they can identify children affected by methamphetamine labs or their own exposure to 
toxic chemicals. Because of the creation of toxic waste at methamphetamine labs, many 
first response personnel incur injury when dealing with the hazardous substances.85 Medical 
evaluation and treatment may be indicated if symptoms of illness develop following contact 
with methamphetamine lab chemicals or residual toxins. Symptoms86 include: 
 
• Chronic cough 
• Chest pain or tightness 
• Shortness of breath 
• Dizziness 
• Headache 
• Skin and eye irritation 
• Chemical burns 
• Nausea 
• Lethargy  
 
In addition to the toxic effects, there are other signs that could signal the presence of a 
methamphetamine lab. These include: 
 
• Unusual, strong odors (like cat urine, ether, ammonia, acetone, or other chemicals) 
coming from sheds, outbuildings or other structures, orchards, campsites, or vehicles 
• Possession of unusual materials, such as large amounts of over-the-counter 
allergy/cold/diet medications (including ephedrine or pseudoephedrine), or large 
quantities of solvents (such as acetone, Coleman fuel, or toluene) 
• Discarded items such as ephedrine bottles, coffee filters with oddly-colored stains, 
lithium batteries, antifreeze containers, lantern fuel cans, and propane tanks 
• The mixing of unusual chemicals in house, garage, or barn, or the possession of 
chemical glassware by persons not involved in the chemical industry 
• Heavy traffic during late hours 
• Residences with operating fans in windows in cold weather or blacked out windows 
• Renters who pay their landlords in cash.87 
 
Through a grant funded by the Children’s Bureau (DHHS), Crowell and Webber at the Illinois 
State University School of Social Work have created a training program for child welfare 
supervisors. This document provides information on signs of client methamphetamine use 
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http://www.drugfreeinfo.org/PDFs/strengthensupervision.pdf. 
 
The California Attorney General’s Office Crime and Violence Prevention Center has created a 
synopsis of information about methamphetamine labs and how to respond. This is excellent 
information for child welfare workers who may be entering a house for the first time. This 
can be found at: http://www.safestate.org/shop/files/clanlab.pdf. 
 
The considerations are complicated for child welfare workers dealing with a case where a 
methamphetamine lab is involved. Family reunification considerations must address the 
issues of child safety and well-being based on the child’s potential exposure to toxic 
substances. Reunifying families where the home environment is literally toxic is problematic. 
Child welfare workers must also consider the possibility of methamphetamine use among 
potential relative caregivers. 
 
5.  Medical Interventions for Children 
 
Drug Endangered Children (DEC) teams have been created in several counties across the 
nation to deal specifically with methamphetamine labs.88 Each DEC team includes a specially 
trained public health nurse, a county physician, and a social worker, to ensure that children 
are properly documented and monitored to keep them away from the dangerous conditions 
of a methamphetamine lab. Children are examined several times during the 18 months 
following identification to ensure that they have not suffered ill effects from the chemicals 
found in methamphetamine labs. During a typical DEC response, a public health nurse 
examines the child at the scene to determine whether emergency health care is needed. If 
not, the child is scheduled for a doctor visit within 48 hours. Follow-up exams are set for 30 
days, six months, a year, and 18 months later. The Office of National Drug Control Policy 
(ONDCP) provides medical protocols for children found at methamphetamine lab sites (See 
Appendix 1). These protocols are color coded to identify the agency responsible for each 
part of the protocol. This document includes:  
 
• A field medical assessment protocol to determine whether children are in need of 
emergency medical care 
 
• An immediate care protocol for those problems that cannot wait 24 hours to be 
treated at the baseline exam; immediate care should be provided as soon as possible 
after significant health problems are identified 
 
• A baseline assessment protocol to ascertain a child’s general health status 
 
• An initial follow-up care protocol to reevaluate the comprehensive health status of the 
child, identify any latent symptoms, and ensure appropriate and timely follow-up of 
services as the child’s care plan and placement are established 
 
• A long-term follow-up care protocol to: 1) monitor physical, emotional, and 
developmental health; 2) identify possible late developing problems related to the 
methamphetamine environment; and, 3) provide appropriate intervention. 
 
Dr. Rizwan Z. Shah, the Medical Director of the Child Abuse Program at Blank Children’s 
Hospital in Des Moines, developed an “effective care plan for drug-exposed infants” (See 
Appendix 2). This treatment plan was developed in response to infants exposed to any 
stimulant and has been effective when used with methamphetamine-affected infants.  
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It is difficult to grasp the true extent of the methamphetamine problem that child welfare 
workers face. Child welfare systems generally do not indicate whether reports of child abuse 
are related to substance abuse in general or methamphetamine use in particular. Much of 
what we know about children living with methamphetamine-using parents comes through 
the criminal justice arena.89  
 
Although DEC teams incorporate medical and child welfare responses, they do not typically 
include substance abuse treatment agencies in their operations. Perhaps DEC teams assume 
that the criminal justice system will motivate parents toward treatment and provide access 
to appropriate treatment programs.  Unfortunately, many jurisdictions do not have the 
structures or linkages in place to effectively address the needs of the parent for treatment. 
Intervention for the parent and entry to treatment programs may be the appropriate 
response in many cases. Research has established the efficacy of treatment programs for 
methamphetamine users. DEC programs focus their energy and attention on the children. It 
is crucial to create linkages between substance abuse treatment providers, child welfare 
services, and the courts, particularly in those jurisdictions that are experiencing increased 
methamphetamine use, in order to achieve positive outcomes for children affected by their 
parent’s methamphetamine use. 
 
 
6.  Treatment Options for Parents 
 
There are various treatment options for methamphetamine users. These include inpatient 
hospitalization for severe cases of long-term methamphetamine dependence, and outpatient 
treatment with behavioral therapies such as cognitive behavioral therapy, contingency 
management, and the Matrix Model.90 Contingency management reinforces the person for 
not using the drug by providing vouchers or other reinforcements. This method effectively 
reduces methamphetamine use during treatment.91 Motivational interviewing and brief 
intervention models also hold promise for early intervention.92 Anglin and colleagues93 
suggest that the optimum treatment for methamphetamine users is an intensive outpatient 
setting where the client receives comprehensive counseling three to five times per week for 
at least the first three months. 
 
Between 1999 and 2001, the Substance Abuse and Mental Health Services Administration, 
Center for Substance Abuse Treatment, supported the largest randomized clinical trial of 
treatment for meth dependence based on the Matrix Treatment Model. The Matrix Model 
provides a structured outpatient treatment program that combines behavioral, educational, 
and 12-step counseling techniques; relapse prevention groups; social support groups; 
individual counseling; family and group sessions; and urine and breath testing.94,95 Clients 
participate in the program three times a week for six months. The program is based on a 
cognitive-behavioral approach, and is designed in phases that decrease in intensity. The 
Matrix Model has been found to retain more than 50% of patients for a clinically meaningful 
treatment episode.96 Evaluations of the Matrix Model have supported its usefulness and 
efficacy with methamphetamine users.97,98,99 The Matrix Model is documented in a manual 
that allows providers to present the program in their own setting. 
 
The findings from these treatment approaches indicate that treatment models for cocaine 
and other substance users are equally effective when used with methamphetamine users. 
The “best practices” developed for treatment of other substances of abuse can also be 
applied in the case of methamphetamine. 
 
Treatment practices may require some modification for methamphetamine users. The 
cognitive deficits found in methamphetamine users, and the tendency for the deficits to 
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worsen in the early phase of recovery, may need to be accommodated. Because the 
impairment of picture recognition is less severe than the impairment of word recognition, 
some treatment programs have relied on visual cues in providing information to clients. 
Methamphetamine users in recovery are more likely to understand and remember handouts 
that include pictures.100 
 
Another issue that needs to be considered in methamphetamine treatment is the generally 
continual pattern of use. Understanding this pattern helps treatment providers and 
substance users identify the circumstances and triggers that may lead to relapse.101  
 
There are no effective pharmacological treatments for methamphetamine dependence at the 
present time. Medication adjuncts to behavioral therapy are being researched.102,103 
 
Recent research into the correlation between methamphetamine use and psychiatric 
disorders, particularly depression and anxiety, has highlighted the need for a mental health 
component in methamphetamine treatment. Treatment outcomes may improve if the 
client’s mental health problems are addressed during treatment.104,105,106 
 
A child welfare worker who encounters a parent in need of treatment for methamphetamine 
use should refer the parent to a treatment agency for a comprehensive assessment. The 
assessment should determine the level of care the person needs and the ancillary services 
they require, including mental health services, medical treatment, housing, parenting 
classes, etc. Once the parent has entered a treatment program, the child welfare worker 
may want to learn what services the parent is receiving in addition to treatment.  
 
 
7.  Treatment Outcomes 
 
Research indicates that treatment outcomes for methamphetamine users are similar to 
those of other drug users, including cocaine users.107,108  In the year following discharge 
from treatment, no differences in treatment outcomes, such as treatment readmission, 
arrests, convictions, and employment, have been found between methamphetamine users 
and users of other substances.109 Methamphetamine users appear to respond to treatment 
in the same way cocaine users respond, and many continue to show improvements with 
increasing length of abstinence.110 The treatment response to a multi-component outpatient 
program has been found to be very similar for users of all stimulant drugs, including 
methamphetamine.111 
 
Relapse rates for methamphetamine users are similar to those for other drugs. A study of 
substance users who were treated in publicly-funded residential or outpatient treatment 
programs in Los Angeles County found a 50% relapse rate for methamphetamine users, 
with 36% of relapses occurring within six months of completing treatment and an additional 
15% within seven to 19 months after treatment.112 The California Drug and Alcohol 
Treatment Assessment (CALDATA) study, which included residential and outpatient 
treatment modalities, found that 60% of methamphetamine users had relapsed at 12 
months, which was similar to users of heroin and cocaine concurrently and marijuana 
abusers, better than heroin abusers, and less successful than cocaine or crack users.113 A 
third study, the Los Angeles Target Cities Treatment Enhancement Project (TCTEP), showed 
that 35% of outpatient methamphetamine users had relapsed at 12 months compared to 
23% of other outpatient drug users, a nonsignificant difference in rates.114  In examining 
gender differences in treatment outcomes, recent study of former clients of a large publicly 
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funded treatment system found no differences in relapse rates among male and female 
methamphetamine users.115 
 
Treatment completion rates for methamphetamine users appear to be similar or somewhat 
lower to that of other drug users.116 One study found that 23.3% of methamphetamine 
users completed treatment, a rate similar to that for users of other drugs throughout 
California.117 Methamphetamine users experienced somewhat greater difficulty in 
completing their programs than users of other drugs, and were marginally more likely to 
leave treatment prior to its completion.118 Several types of methamphetamine users were 
found to be significantly more likely to complete treatment: those who were over 40 years 
old, those who had less severe drug use patterns (did not use every day or did not inject), 
and those who were ordered into treatment by the criminal justice system.119 
Methamphetamine users who did not complete their treatment program either relapsed and 
did not return to the program or were asked to leave.120 
 
The relapse rates and treatment retention rates of methamphetamine users may reflect the 
cognitive impairments and mental health issues such as depression and anxiety that may 
arise and persist during recovery. Women often cite “to help with depression,” as one of the 
reasons that they initiate methamphetamine use. If these issues are addressed in a 
comprehensive treatment program, relapse and retention rates may improve.  
 
Child welfare workers should be familiar with the treatment options available in their 
communities. Because a high percentage of those who enter treatment experience relapse, 
case plans need to include a contingency plan to cover the possibility of relapse. The case 
plan should specify an individual the child can stay with to remain safe. 
 
 
8.  Summary 
 
As child welfare workers encounter children affected by their parents’ use of 
methamphetamine, they need accurate information about the drug, its effects on parents, 
the potential dangers to children, the efficacy of treatment, and the possibility of recovery 
for the parent.  
 
Methamphetamine is a dangerous drug that can lead to severe problems for users and puts 
their children at risk. However, research indicates that the physiological damage created by 
methamphetamine use is reversible with long-term abstinence. Research also shows that 
treatment models that work for addiction to other substances are also effective for 
methamphetamine addiction. Treatment outcomes for methamphetamine users appear to 
be similar to those for users of other drugs. Successful treatment for the parent may lead to 
family reunification and resultant benefit to both the child and the parent. 
 
In dealing with the children of methamphetamine-using parents, child welfare workers must 
be alert to the immediate and long-term symptoms of exposure to the drug itself and the 
chemicals used in its manufacture. They must also be aware of the potential dangers to 
children in a methamphetamine manufacturing situation. They need to understand the 
danger they themselves face in visiting a location where methamphetamine may be 
produced. See Appendix 3 for additional resources related to methamphetamine prevention 
and treatment. 
 
Child welfare workers must take into consideration the cognitive impairments that result 
from prolonged use. Residual impairments may be apparent for a year or more after 
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treatment begins. A parent who appears unwilling to meet case plan requirements may in 
fact be unable to meet the requirements without additional support. 
 
The issue of prenatal exposure requires attention as well. Early intervention, effective 
treatment, and supportive follow-up are the keys to ensuring that a healthy baby is born to 
a healthy mother. 
 
Methamphetamine-using parents may have needs beyond treatment for addiction, such as 
needs for mental health services, medical services, housing, and employment. Their children 
may have needs beyond safety from immediate harm. The most effective approach to the 
problem of methamphetamine-using parents and their at-risk children is a comprehensive 
integrated services strategy, where treatment includes a range of services that support the 
parent in leaving addiction behind and stepping into the role of a positive, successful parent.  
 
Appendix 1
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Appendix 2 
Second Chance Kids 
Providing Development Focused Care For Drug-Exposed Infants 
By Rizwan Z. Shah, M.D., FAAP 
 
It is generally assumed that pregnant women will provide a healthy environment for their 
unborn children and know how to avoid harmful consequences for the unborn. But this is 
not so when the compulsive need to remain high on addictive drugs of abuse, such as crack 
cocaine and other substances, supersedes the need to protect the welfare of unborn 
children.  
Women who use drugs during pregnancy expose their unborn children to harmful effects of 
illicit drugs at the critical period of neurological development as well as physical growth. 
Scientific evidence regarding the impact of some drugs such as alcohol, heroine and crack 
cocaine are better understood than the impact of methamphetamine on infants exposed 
prenatally to these drugs.  
During the 1980s epidemic of crack cocaine use, clinical observations documented a variety 
of possible abnormalities among infants of mothers who used crack cocaine during 
pregnancy. These initial observations paved the way for more concrete science-based 
research into the effect of crack cocaine on fetal development and the infant’s outcome. 
Even though the earlier fears regarding possibility of “crack kids” leading a wasteful 
vegetative life have been allayed, concerns regarding subtle neurological problems are 
mounting as new technology helps researchers document brain function abnormalities with 
accuracy not possible in the 80s.  
The ultimate goal of scientific research and service providers remains focused on providing 
the best possible options for drug-exposed infants to achieve better outcomes for 
developmental and academic functioning.  
For pregnant women abusing cocaine or other drugs, early and regular prenatal care can 
provide protection against known complications of pregnancy such as premature birth, 
abruption of placenta, high blood pressure and fetal death. Both crack cocaine and 
methamphetamine are stimulants with the potential to cause blood vessel spasms resulting 
in compromising oxygen and blood supply to fetal brain and other organs vital for future 
functioning of the child. In fact, drug abuse at any stage of pregnancy can compromise 
infant outcome.  
EFFECTIVE CARE PLAN FOR DRUG-EXPOSED INFANTS: 
Treatment plans based upon systematic behavior observations of drug-exposed infants 
provide effective and developmentally appropriate intervention with successful outcome 
potential.  
Age-related intervention plans can be organized in the following time spans of early life of 
drug-exposed infants:  
1) 0–6 Months: Problem areas to focus on are:  
Habituation Orientation: Soon after birth, infants need to develop skills to adjust stimulus 
input from their environment. For instance, infants learn to watch people’s faces, react to 
light, darkness and sounds and learn to take interest in their surroundings. These skills are 
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established in the central nervous system based upon maturity and infant-receptor sites. 
Drug-exposed infants demonstrate poor orientation and habituations in responding to 
environmental stimuli. They either sleep too much or not enough, and they turn away from 
visual contact, disregarding objects in the surroundings.  
Care Plan: By recognizing alert and passive cycles, the care giver can provide appropriate 
interactive input for necessary neuromotor development. Planning meal time for an infant 
who is born small for age and has poor suck coordination requires an organized approach to 
scheduled meal times, rather than waiting for the infant to ask for nourishment. Likewise, 
avoiding overstimulation for a child who is in down time is equally important.  
Interaction Attachment: Providing opportunities for physical contact, visual regard and 
verbal interaction becomes an integral part of social development in early stages of life.  
Response to Stress: A nonverbal child gives out many signals to indicate stress-generated 
anxiety. These symptoms range from changes in breathing, heart rate and temperature to 
stiffened arms and legs with obvious shaking; in the face of continued stress, the symptoms 
can escalate to inconsolable screaming and breath-holding with vomiting and turning blue.  
To Minimize Stress: A care plan to deal with stress-related symptoms should include:  
• Providing quiet, calm environment without noise or bright lights.  
• Providing warmth and comfort by bundling the child in blankets.  
• Encouraging habituation by providing sucking opportunity with pacifier.  
• Initiating gentle rocking or soothing motions to help achieve neurobehavioral 
organization.  
2) 6 Months–2 Years: Most drug-exposed children should achieve mastery of 
neurobehavioral organization by the end of 6 months. The age group 6 months to 18 
months is typically called “honeymoon” period of development for drug-exposed infants 
where for all outside measures the child remains symptom-free. By the end of this period, 
speech and language development difficulties that require follow-up care can surface.  
3) 3 Years of Age and Older: The potential for slight difficulty in focusing on tasks or in 
settling down in preschool years may get progressively worse with more demands on 
focused tasks in school years, and a child showing minor difficulty in controlling emotions 
may encounter significant social adjustment difficulties in later childhood. These problems 
get worse with high-risk social environment and unstable family units.  
SUMMARY To summarize this complicated issue, a well-organized, developmentally oriented 
approach toward early recognition and intervention has the best chance to be a successful 
treatment outcome for drug-exposed children. Even though current research is reassuring 
regarding the “damaged goods” picture that earlier observations had painted, continued 
developmental surveillance is required to recognize minor difficulties early so that major 
problems are avoided later on in life. A team approach of health professionals, parents, 
early childhood educators and local support network is essential for achieving this goal. 
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METHAMPHETAMINE AND ITS IMPACT ON WOMEN, CHILDREN AND FAMILIES: 
INVENTORY OF SELECT RESOURCES 
 
 
This document is intended to identify some of the major resources related to 
methamphetamine prevention and treatment. The listing of resources is organized in 11 
major topic areas as follows:  
 
CATEGORY                          PAGE 
1. NATIONAL AND STATE DRUG ENDANGERED CHILDREN (DEC) MATERIALS AND 
PROTOCOLS..................................................................................................... 20 
2. OTHER METHAMPHETAMINE-RELATED PROTOCOLS AND RESOURCES....................... 21 
3. SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ADMINISTRATION (SAMHSA) 
PUBLICATIONS AND RESOURCES ........................................................................ 22 
4. NATIONAL INSTITUTE ON DRUG ABUSE (NIDA) PUBLICATIONS............................... 23 
5. OTHER MAJOR REPORTS AND PUBLICATIONS ....................................................... 24 
6. FEDERAL METHAMPHETAMINE CONFERENCES....................................................... 26 
7. THE METHAMPHETAMINE CLEARINGHOUSE .......................................................... 26 
8. CLANDESTINE LABS AND HIGH INTENSITY DRUG TRAFFICKING AREAS.................... 27 
9. METHAMPHETAMINE TRAININGS ......................................................................... 27 
10. UCLA INTEGRATED SUBSTANCE ABUSE PROGRAMS (ISAP)..................................... 28 
11. VIDEOS FROM WASHINGTON STATE’S ALCOHOL AND DRUG CLEARINGHOUSE .......... 29 
 
 
This document can be found at http://www.ncsacw.samhsa.gov
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1. National and State Drug Endangered Children (DEC) Materials and Protocols 
 
y Drugs and Society: The True Cost to YOU! Drug Endangered Children (September 
2004).  The goal of this broadcast is to educate the public about the problem of 
methamphetamine and its effects on children, provide solutions, and present ways 
that coalitions can become more involved in protecting children and reducing the 
tragic human costs associated with drug abuse.  The discussion features Deborah 
Augustine, Victim Witness Program Manager, Drug Enforcement Administration; Ron 
Mullins, Coordinator, National Drug Endangered Children Alliance; and John Martyny, 
Associate Professor, Division of Environmental and Occupational Health Sciences, 
National Jewish Medical & Research Center. 
http://www.health.org/multimedia/mediaDetails.aspx?ID=269 
 
y Arizona Drug Endangered Children (DEC) Multidisciplinary/Integrated Protocol 
(September 30, 2003).  http://www.ag.state.az.us/DEC/DEC_protocol.pdf 
 
y National Protocol for Medical Evaluation of Children Found in Methamphetamine Labs 
(prepared by the National Alliance for Drug Endangered Children). 
http://www.colodec.org/decpapers/Documents/DECNationalProtocol.pdf 
 
y Medical Protocols for Children Found at Meth Lab Sites (prepared by the California 
DEC Resource Center, June 1999). 
http://www.doh.wa.gov/ehp/ts/CDL/CA%20DEC%20Medical%20Protocol.pdf   
 
y Protocol for Investigating Child Protection Referrals Involving the Operation of 
Clandestine Labs (prepared by Larimer County, Colorado). 
http://www.colodec.org/decpapers/LarimerCoProtocol.htm 
 
y Minnesota Medical Protocols for Children Found at Methamphetamine Lab Sites 
(September 2003).  
http://www.health.state.mn.us/divs/eh/meth/training/protocolsum.pdf 
 
y The Nebraska CHEM-L Protocol (version 4, January 2004).  This protocol was 
developed by a Medical Working Group as part of the Midwest High Intensity Drug 
Trafficking Area (HIDTA) Program. http://ccfl.unl.edu/projects/cprojects/chem-l/ 
 
y Drug Endangered Children Protocol for Tacoma-Pierce County (Washington State) 
http://www.doh.wa.gov/ehp/ts/CDL/decpierce.pdf 
 
y Stevens County Sheriff’s Office Meth Site Child Response Protocol (Washington 
State) http://www.doh.wa.gov/ehp/ts/CDL/decstevens.pdf 
 
y Drug Endangered Children – Initial Response Forms.  Contains a set of 8 forms that 
include: 1) Review of hazards to children in a clandestine lab environment, 2) 
Chemicals of a clandestine drug lab – rooms where found, 3) Clandestine drug lab 
chemicals, 4) Order of protection C.R.S. 19-3-405/Protective hold C.R.S. 19-3-401, 
5) Medical information form, 6) Medication form, 7) Methamphetamine lab medical 
charting form, and 8) Medical protocols for children found at meth lab sites.  Though 
compiled for Colorado, other states may find these useful or want to modify them for 
their efforts.  
http://www.colodec.org/decpapers/Documents/DECBestPracticesInitialResponseForm
s.pdf 
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y Memorandum of Understanding. This MOU between the Larimer County Department 
of Human Services and the Larimer County Drug Task Force to assist in the 
identification, investigation and the removal of Drug Endangered Children from 
hazardous drugs usage and manufacturing locations found within the Larimer County 
Law Enforcement jurisdictions. 
http://www.colodec.org/decpapers/LarimerCoMemo.htm 
 
y Clandestine Methamphetamine Labs FAQ #1 (prepared by Dr. Kathryn Wells, Medical 
Director, Denver Family Crisis Center). 
http://www.colodec.org/decpapers/clandestinelabfaq1.htm 
 
y Medical Evaluation of Children Removed from Clandestine Labs FAQ #2 (prepared by 
Dr. Kathryn Wells, Medical Director, Denver Family Crisis Center). 
http://www.colodec.org/decpapers/childmedevalfaq2.htm 
 
y How to Care for Children Removed from a Drug Endangered Environment FAQ #3 
(prepared by Dr. Kathryn Wells, Medical Director, Denver Family Crisis Center).  
http://www.colodec.org/decpapers/careforchildrenfaq3.htm 
 
y Medical Concerns Regarding Clandestine Labs. (prepared by Dr. Kathryn Wells, 
Medical Director, Denver Family Crisis Center). 
http://www.colodec.org/decpapers/medcncrnsclandestinelabs.htm 
 
y Tennessee’s Child Protective Services Investigation of Children Exposed to Chemical 
Laboratories for the Manufacture of Methamphetamine.  This sets forth the policies 
and procedures for all Tennessee Department of Children’s Services CPS employees.  
It was originally issued in 2001 and revised in 2002. 
http://www.state.tn.us/youth/policies/Chapter%2014%20Child%20Protective%20Se
rvices/14-
28%20CPS%20Investigation%20of%20Children%20Exposed%20to%20Chemical%2
0Labs-.pdf 
 
y Tennessee Department of Children’s Service Resource Data on Methamphetamine.  
The Department of Children’s Services put this together this resource document from 
information from the DEA, NIDA, the Tennessee National Guard and the Koch Crime 
Institute.  It includes suggested protocol for assessing medical needs of children 
found at methamphetamine labs. 
http://www.state.tn.us/youth/policies/Chapter%2014%20Child%20Protective%20Se
rvices/Resource%20Data%20on%20Methamphetamines.pdf  
 
2. Other Meth-Related Protocols and Resources 
 
y Recommendation of Work Practices to Maintain Officer Safety. These 
recommendations are based on draft guidelines developed by the California 
Department of Justice Bureau of Narcotics Enforcement.  
http://www.publichealth.arizona.edu/divisions/envirocom/officer/phase_iii_final-
officer_safety.doc 
 
y Second Chance Kids: Providing Development Focused Care for Drug-Exposed Infants 
(2000).  This document discusses the development of treatment plans for drug-
exposed infants that provide effective and developmentally appropriate interventions 
with successful outcome potential.  Prepared by Rizwan Z. Shah, M.D., Medical 
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Director, Child Abuse Program, Blank Children’s Hospital, Des Moines, IA 
http://www.addictionrecov.org/paradigm/P_PR_SP00/cont_shah.htm 
 
y Project Strengthening Supervision: A Training Program for Child Welfare Supervisors.  
Signs of Client Methamphetamine Use and Caseworker Safety Procedures (2001).  
This training program, which was provided through Illinois State University, School of 
Social Work, provided participants with the knowledge and skills necessary to 
maintain their safety and well-being when working with methamphetamine-involved 
clients.  An outline of the training is available at 
http://www.drugfreeinfo.org/PDFs/strengthensupervision.PDF.  The Illinois 
Department of Children and Family Services is currently considering adopting this 
particular module as part of its training package.  For more information, please 
contact J. Randall Webber, M.P.H., Director of Training and Publications, Lighthouse 
Institute at Chestnut Health Systems, 309.820.3543 x8-3411, 
Rwebber@chestnut.org 
 
• Meth: A Reference Guide for Illinois Law Enforcement and Courts (2004). This guide 
was authored by a multidisciplinary group of law enforcement officers, State’s 
attorneys and prosecutors, and judges.  The Reference Guide contains information 
on topics such as the methamphetamine problem in Illinois; indicators and hazards 
of making methamphetamine; law enforcement investigation; methamphetamine 
abuse and treatment; protection of children exposed to methamphetamine labs; 
methamphetamine charges and litigation; and Illinois case law.  The guide and 
accompanying materials are expected to be available online and in CD format soon.  
For more information, please visit 
http://cspl.uis.edu/ILAPS/TrainingPrograms/MethProtocol/ 
 
• Reconnecting Youth – Methamphetamine Component.  With funding from 
SAMHSA/CSAP and the Department of Education, Iowa has developed a 
methamphetamine component to be added to the Reconnecting Youth curriculum.  
For more information, please contact Janet Zwick, Deputy Director, Iowa Department 
of Public Health, 515-281-4417; or Robin Heinemann (curriculum developer and 
trainer), Dr. Jerry Stubben (co-principal investigator) or Dr. Cathy Hockaday (co-
principal investigator) at Iowa State University, Institute of Social and Behavioral 
Research, 515-294-4518.  
 
3. Substance Abuse and Mental Health Services Administration (SAMHSA) Publications and 
Resources 
 
y The DASIS Report:  Trends in Methamphetamine / Amphetamine Admissions to 
Treatment, 1993-2003 (2006).  This report discusses rates, demographics and 
geographic distribution for methamphetamine treatment admissions for the period 
1993 to 2003.  http://www.oas.samhsa.gov/2k6/methTX/methTX.cfm 
   
y METH: What's Cooking in Your Neighborhood? (Myths, Facts, and Illicit Drugs: What 
You Should Know Series) (2001). This 30-minute video explains myths and facts 
surrounding methamphetamine. Viewers will learn about its many physical, 
psychological, and economic consequences for individuals, families, and 
communities. It includes highlights from "Meth: What's Cooking in Your 
Neighborhood?," one in a series of national 90-minute drug-specific teleconferences 
sponsored by the Office of National Drug Control Policy, SAMHSA, NIDA, the National 
Guard Counterdrug Office, and the Community Anti-Drug Coalitions of America. 
http://store.health.org/catalog/productDetails.aspx?ProductID=16038  
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y Treatment for Stimulant Use Disorders: TIP 33 (1999). This Treatment Improvement 
Protocol (TIP) supplies substance use disorder treatment providers with vital 
information on the effects of stimulant abuse and dependence, discusses the 
relevance of these effects to treating stimulant users, describes treatment 
approaches that are appropriate and effective for treating these clients, and makes 
specific recommendations on the practical application of these treatment strategies. 
The treatment strategies that are described in this TIP have been scientifically 
validated as effective in treating people with stimulant use disorders. These 
strategies address the specific problems and needs that are inherent to chronic 
stimulant users. http://www.health.org/govpubs/bkd289/ 
 
y Methamphetamines: A Guide for Parents and Other Caregivers (1999). This CSAP 
Substance Abuse Resource Guide provides information on methamphetamine 
categorized in three areas: prevention materials, studies, articles and reports, and 
national organizations for substance abuse prevention. 
 
y The Methamphetamine Treatment Project (MTP) is a multi-site initiative funded by 
SAMHSA/CSAT to study the treatment of methamphetamine dependence. Jointly 
implemented by the UCLA Integrated Substance Abuse Programs (ISAP), and the 
Matrix Institute on Addictions, its goal is to generate knowledge regarding how the 
Matrix comprehensive treatment protocol can be effectively transferred to the 
community drug treatment system.  The web site 
(http://www.methamphetamine.org) provides information about the project, results 
when they become available, as well as general information on methamphetamine 
abuse and treatment and links to other useful sites.  In addition, the April-June 2000 
issue of the Journal of Psychoactive Drugs describes the efforts and progress of the 
MTP and includes more than a dozen articles on various aspects of the project. 
 
y Methamphetamine 101. This video created by the Addiction Technology Transfer 
Center (ATTC) provides information about the etiology and physiology of an 
epidemic. This video is designed to provide an overview of the medical, psychological, and 
societal effects of methamphetamine abuse and dependence, and is intended to be used in 
conjunction with the second module addressing methamphetamine treatment. 
http://www.abhp.arizona.edu/Training/Store/index.aspx#Meth101 
 
y Methamphetamine 102. This second video by the ATTC provides information about 
evidence-based treatment and addresses foundations for a clinical approach to 
methamphetamine treatment with emphasis on the Matrix Model, an evidence-based 
treatment protocol that has withstood the rigors of clinical trial research. 
http://www.abhp.arizona.edu/Training/Store/index.aspx#Meth102 
 
4. National Institute on Drug Abuse (NIDA) Publications 
 
y A Community Reinforcement Plus Vouchers Approach: Treating Cocaine Addiction. 
Therapy Manuals for Drug Addiction (1998). This manual has been empirically tested 
with stimulant-using populations. Although the materials have been developed and 
tested with cocaine and crack users, evidence to suggest that cocaine and 
methamphetamine users respond quite similarly to behavioral and cognitive-
behavioral strategies. http://www.nida.nih.gov/TXManuals/CRA/CRA1.html 
 
  
                                                                                       24
y NIDA Community Drug Alert Bulletin – Methamphetamine (1998). This bulletin 
provides a condensed version of some of the latest scientific information on 
methamphetamine. http://www.drugabuse.gov/MethAlert/MethAlert.html 
 
y Methamphetamine Abuse and Addiction: NIDA Research Report Series (Printed April 
1998, reprinted January 2002). NIDA's Research Reports simplify the science of 
research findings for the educated lay public, legislators, educational groups, and 
practitioners. The series is updated periodically to reflect current knowledge on drugs 
of national interest.  
http://www.drugabuse.gov/ResearchReports/methamph/methamph.html 
 
y Mind Over Matter (1998). This NIDA series is designed to encourage young people in 
grades five through nine to learn about the effects of drug abuse on the body and 
the brain. There is a section specifically on methamphetamine.   
http://www.drugabuse.gov/MOM/MOMIndex.html 
 
5. Other Major Reports and Publications 
 
Federal/National Reports 
 
y Methamphetamine and Other Substance Use During Pregnancy: Preliminary 
Estimates From the Infant Development, Environment, and Lifestyle (IDEAL) Study 
(2006). This article highlights preliminary estimates from a longitudinal study, 
supported by a grant from the National Institute on Drug Abuse. The purpose of the 
study is to estimate the prevalence and correlates of alcohol, tobacco, and other 
substance use during pregnancy, including methamphetamine. This is the first large-
scale investigation to report the prevalence of methamphetamine use during 
pregnancy in areas of the United States where methamphetamine is a notable 
concern. Follow-up research is ongoing to investigate the outcomes associated with 
prenatal methamphetamine exposure. 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Ci
tation&list_uids=16395620 
 
y Methamphetamine Interagency Task Force Final Report 2000 (2000).  This report 
lays out guiding principles, needs and recommendations, and research priorities to 
inform future prevention and education, treatment, and law enforcement efforts.  It 
also identifies a number of themes to inform future efforts to implement a national 
strategy to address methamphetamine. 
http://www.ncjrs.org/pdffiles1/nij/180155.pdf 
 
y Methamphetamine – Drug Facts (2005).  This ONDCP fact sheet provides an 
overview on methamphetamine, the extent of use, health effects, treatment, arrests 
and sentencing, production and trafficking, and legislation, as well as links to other 
sources. 
http://www.whitehousedrugpolicy.gov/drugfact/methamphetamine/index.html   
 
y Children at Clandestine Methamphetamine Labs: Helping Meth’s Youngest Victims. 
(June 2003).  This Office for Victims of Crime (OVC) Bulletin provides an overview of 
methamphetamine production and trends and discusses the dangers to children 
living in methamphetamine labs.  It also outlines recommendations for a 
multidisciplinary team approach to meet the needs of children found at clandestine 
labs, and highlights some promising practices in the field. 
http://www.ojp.usdoj.gov/ovc/publications/bulletins/children 
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y The Methamphetamine Problem: A Question and Answer Guide (n.d.) This guide, 
prepared by the Institute for Intergovernmental Research, addresses a wide range of 
questions on methamphetamine including how meth is made, its effects, treatment, 
and strategies to combat the problem. http://www.iir.com/centf/guide.htm 
 
State/Local Reports 
 
y The Governor’s Task Force on Methamphetamine Abuse: Final Report (September 1, 
2004).  This report provides recommendations from the Governor’s Task Force on 
Methamphetamine that are intended to serve as the basis for a comprehensive 
strategy to address the methamphetamine epidemic in Tennessee.  The 
recommendations are categorized under seven fundamental “cornerstones,” 
including increased funding for methamphetamine treatment with an eye toward 
long-term initiatives and committing resources to help children harmed by 
methamphetamine manufacturing and abuse.  
http://kci.org/meth_info/methreport.pdf 
 
y Final Report of the Joint House-Senate Task Force on Ice and Drug Abatement 
(January 2004).  This report, prepared by a Hawaii legislative task force studying 
methamphetamine use in the state, includes a package of legislative proposals 
geared more toward education, prevention and treatment rather than increased law 
enforcement strategies.  Spending priorities for the $21.6 million dollar set of 
programs include: $10.7 million for adult drug treatment, $4.5 million for teen 
intervention and drug treatment, $3.5 million for drug abuse prevention for families, 
schools, and youth programs, $1.2 million for expanded drug court programs, 
$850,000 to fund the state's “treatment not jail” program for first-time, nonviolent 
drug offenders, and $300,000 to study the impact of ice labs on Hawaii's 
environment, particularly groundwater supplies. 
http://www.capitol.hawaii.gov/sessioncurrent/lists/ice_finalrpt.pdf 
 
y Narratives from County Survey on Methamphetamine Impact on Social Service 
Delivery in North Dakota (2003). The North Dakota Division of Children and Family 
Services surveyed the county social services offices on August 22, 2003, with three 
questions assessing the role methamphetamine use, manufacture or selling has in 
the placement of children in foster care, as well as other kinds of consequences 
within the child welfare system. At the time of the survey, there were 865 children in 
care through either county social services or the Division of Juvenile services. The 
response rate to the survey was 88% (758 responses). The survey found that 
methamphetamine use has had a significant impact on the child welfare system, not 
only in the numbers of children placed in foster care, but also in the number of 
reports of child abuse and neglect that the county offices are assessing and the 
complexity of the issues surrounding the children who are being served. This 
document contains some of the open-ended comments received. 
http://www.state.nd.us/humanservices/info/testimony/2003/gov-
services/030917b.html 
 
y Methamphetamine in Illinois: Examination of an Emerging Drug (2003). Research 
Bulletin. 1:2. This bulletin demonstrates how key indicators can be used to measure, 
monitor and evaluate the extent and nature of meth abuse in Illinois. Published by 
the Illinois Criminal Justice Information Authority. 
http://www.icjia.state.il.us/public/pdf/bulletins/meth.pdf 
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y Responding to Methamphetamine: Washington State’s Promising Example (2002).  
This report documents the process and initial results of Washington State’s 
methamphetamine initiative, which brought together law enforcement, criminal 
justice, health, treatment, education, child and family services, environmental 
protection, government, and youth to discuss action steps and strategies to address 
the meth problem.  http://www.ncpc.org/cms/cms-
upload/ncpc/files/RespondtoMeth.pdf    
 
y Wyoming's Methamphetamine Initiative: The Power of Informed Process (2001), 
http://www.ncjrs.org/pdffiles1/bja/186266.pdf and Wyoming Methamphetamine 
Treatment Initiative (2002), http://www.ncjrs.org/pdffiles1/nij/grants/194103.pdf 
discuss Wyoming’s initiative. 
 
y Meth Matters: Report on Methamphetamine Users in Five Western Cities (1999).  
This study, supported by the National Institute of Justice (NIJ) and conducted by the 
Criminal Justice Research Division of the San Diego Association of Governments 
(SANDAG), documented methamphetamine use and its consequences among 
arrestees in Los Angeles, Phoenix, Portland, San Diego and San Jose.  The study 
used data from the Arrestee Drug Abuse Monitoring (ADAM) program. 
http://www.ncjrs.org/pdffiles1/176331.pdf. 
 
6. Federal Methamphetamine Conferences 
 
y In September 2000, SAMHSA/CSAT convened a methamphetamine conference, 
Meeting the Challenge: Treatment, Prevention, and Research. This two-day 
conference brought together stakeholders from the treatment, child welfare, law 
enforcement, research, policymaking and other arenas to discuss a broad range of 
methamphetamine-related issues. The agenda is available at 
http://www.methamphetamine.org/docs/AttachmentAConferenceAgenda.doc and the 
conference summary is available at 
http://www.methamphetamine.org/docs/SummarywithAttachmentD.doc 
 
y In 1997, ONDCP convened The National Methamphetamine Drug Conference in 
Omaha, Nebraska. This three-day conference brought together experts from the 
fields of law enforcement, prevention, and treatment at federal, state and local 
levels, as well as business and public interest groups from across the country. More 
than 375 attendees from 35 States and territories participated. A summary of the 
conference and proceedings from the plenary, panel and workshop presentations are 
available at 
http://www.ncjrs.org/ondcppubs/publications/drugfact/methconf/contents.html 
 
7. The Methamphetamine Clearinghouse 
 
y The Methamphetamine Clearinghouse (http://www.ncpc.org/ncpc/ncpc/?pg=5882-
2006-11324-9654) was developed by the National Crime Prevention Council (NCPC) 
to provide a forum for the dissemination of effective practices related to reducing the 
production, distribution, and use of methamphetamine. Particular attention is paid to 
the areas of law enforcement, courts, drug endangered children, treatment, 
prevention, public awareness, and clan lab clean-up. The database will house best 
practices, emerging strategies, training curricula, legislation, city ordinances, 
protocols, strategic plans, interagency initiatives, individual agency initiatives, and 
examples, information, or other materials. 
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8. Clandestine Labs and High Intensity Drug Trafficking Areas 
 
y Developing a Strategy for Multiagency Response to Clandestine Drug Laboratories 
(written 1993; reprinted 2000). This BJA monograph identifies and discusses eight 
essential components of a successful CLEP; outlines a 5-stage strategic planning 
process to developing and implementing a CLEP; provides worksheets to assist 
policymakers and program planners with the strategic planning process; and includes 
models of forms and procedures that State and local agencies can use to develop 
their own CLEP. http://www.ncjrs.org/pdffiles/clan.pdf  
 
y Clandestine Drug Labs. Problem-Oriented Guides for Police, Series No. 16. (2002). 
This guide, published by the Department of Justice’s Office of Community Oriented 
Policing Services (COPS), provides information for police on prevention and how to 
improve overall response to incidents involving clandestine drug labs.  
http://www.cops.usdoj.gov/mime/open.pdf?Item=274. 
 
y Design for a HIDTA/OCDETF Performance Monitoring and Management System: 
Technical Report (January 2003).  Washington, DC:  Office of National Drug Control 
Policy.  http://www.whitehousedrugpolicy.gov/pdf/hidta_ocdetf.pdf 
 
9. Methamphetamine Trainings   
 
y California Addiction and Training Education Series (CATES). The CATES is a series of 
one-day trainings designed to provide in-depth information to individuals working 
with substance using populations. With support from Pacific Southwest ATTC, UCLA 
Integrated Substance Abuse Programs (ISAP), and others, CATES is holding a series 
of three methamphetamine conferences across California. The first was March 30, 
2004 in Pasadena; the second was June 11 in San Francisco and the third was 
August 20 in Sacramento. Workshop PowerPoints from the first training are available 
at http://www.psattc.org/events/cates/I/presentations/index.html. 
 
y New England ATTC Training. Beginning in August of 2004, the New England ATTC 
offered a four-week, credited, online course entitled, “Speed Still Kills: The Growing 
Methamphetamine Problem.” This presentation consists of an overview of 
methamphetamine; its history; patterns of use (including various forms and methods 
of injection, and geographical patterns of use); physical and psychological effects; 
comparison of methamphetamine and cocaine related problems; and a discussion of 
the treatment issues critical for successful methamphetamine dependence treatment.  
http://www.attc-ne.org/education/index.html.  
 
y Community Policing for America's Future: National Community Policing Conference 
(June 21-23, 2004).  This DOJ conference featured workshops grouped into seven 
subject tracks: Homeland Security, Integrity, Effective Technology, School and 
Campus Policing, Problem-Solving Strategies, Partnerships, and Contemporary 
Issues in Community Policing. The workshops in each track addressed critical law 
enforcement and community issues and emphasized the importance of collaboration 
between police and citizens.  Laura Birkmeyer and Ron Mullins were speakers at this 
conference.  http://www.cops.usdoj.gov/mime/open.pdf?Item=1270  
 
y Inaugural Drug Endangered Children National Conference (June 29-30, 2004).  The 
National Alliance for Drug Endangered Children held their inaugural “Drug 
Endangered Children National Conference” in Denver, Colorado. Speakers included 
Laura Birkmeyer, Assistant U.S. Attorney; Ron Mullins, DEC National Training 
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Coordinator; and Sue Webber-Brown, Butte Interagency Narcotic Task Force.  
Resources are available through their website. http://colodec.org 
 
y 17th Annual National Prevention Network Prevention Research Conference (August 
22-25, 2004). This annual conference, sponsored by the Southwest Prevention 
Center at the University of Oklahoma, featured two workshops on 
methamphetamine. The “Prevention of Methamphetamine Use” workshop highlighted 
prevention efforts in three different states: Kansas, Michigan, and Washington. The 
“Crank it Up! Successful Strategies for Addressing Meth in Your Community” 
workshop discussed the Kansas Methamphetamine Prevention Project. 
 
y Idaho’s Second Annual Drug Endangered Children Conference (September 14-16, 
2004). This conference offered information to professionals from a variety of fields; 
each with roles in drug endangered children issues. The presentations covered 
current information on topics relating to medical testing, chemical exposure, child 
victimization, parental accountability, drug courts, fostering drug endangered 
children, and a wide array of other educational topics. Presentations from this and 
the first conference (July 8-10, 2003 in Boise) are available on the web. 
http://www.isp.state.id.us/DEC_Conference/  
 
y Southern Illinois Meth Awareness Conference (October 18-19, 2004). This two-day 
seminar, hosted by the John A. Logan College Center for Business and Industry, 
brought local agencies together to tackle the methamphetamine epidemic that 
southern Illinois is experiencing. Experts in the fields of law enforcement, medical, 
child and family, environmental, and treatment informed southern Illinois 
professionals on procedures and protocols needed to respond to the meth problem.  
http://www.jal.cc.il.us/bus_ind/methconf.html 
 
y National Methamphetamine Legislative and Policy Conference (October 25-27, 2004).  
This conference, offered by the National Alliance for Model State Drug Laws 
(NAMSDL), focuses on legislative and policy options toward creating effective, 
comprehensive, and coordinated responses to issues such as protecting children 
found at methamphetamine labs, protecting families affected by addiction, 
controlling precursor chemicals used to produce meth, and environmental clean-up 
and liability. For more information, please contact Amy Powell, Deputy Director of 
NAMSDL, at 703.836.6100 x18 or amypowell@natlalliance.org 
 
y Western Conference on Addictions: Best Practices in Treatment and Community 
Interventions (November 11-14, 2004).  This conference features top researchers 
and therapists in the substance abuse field. Richard Rawson, Ph.D., from UCLA 
Integrated Substance Abuse Programs (ISAP), is a featured plenary speaker and 
presents on the “Latest Research on Methamphetamine Abuse and Treatment.”  For 
more information, go to http://www.psattc.org/events/11-11-04.html  
 
10. UCLA Integrated Substance Abuse Programs (ISAP) 
 
UCLA ISAP coordinates substance abuse research and treatment under authority of the 
UCLA Neuropsychiatric Institute & Hospital (NPI&H). NPI&H is a division of the UCLA 
Department of Psychiatry and Biobehavioral Sciences, housed within the David Geffen 
School of Medicine at UCLA. The integrated components of ISAP include four 
organizations:  Pacific Node of the NIDA Center for Clinical Trials Network, Matrix 
Institute on Addictions, UCLA Addictions Studies Neurobiology Unit, and UCLA Substance 
Abuse Service Inpatient Unit.   
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Much of ISAP’s work has focused on methamphetamine and the ISAP website 
(http://www.uclaisap.org/) includes a number of PowerPoint presentations, findings and 
abstracts from their efforts. Two ISAP projects of note are the CSAT Methamphetamine 
Treatment Project (MTP) discussed above (see ##) and The Methamphetamine Abuse 
Treatment - Special Studies (MAT-SS), a collection of three separate research studies – 
the Multiyear Follow-up Study, Treatment Adherence Study, and the Cost Analysis Study 
– that build on the MTP.  
 
11. Videos from Washington State’s Alcohol and Drug Clearinghouse  
 
The following videos are available through Washington State’s Alcohol and Drug 
Clearinghouse (http://clearinghouse.adhl.org/video/A-Z_html/M.html) 
 
Methamphetamine Addiction Treatment Forum-Part 1: “Myths and Facts About Meth 
Addiction” (2001).  Methamphetamine Forum focusing on the treatment of 
methamphetamine addiction, held in Tacoma, WA on December 7, 2001.  
 
Methamphetamine Addiction Treatment Forum-Part 2 “Dealing with the Issue” 
(2001). Methamphetamine Forum focusing on the treatment of methamphetamine 
addiction, held in Tacoma, WA on December 7, 2001.  
 
Methamphetamine: The Crystal Cage (1998) Designed for teens, this video 
extensively interviews five former users as a means of exploring the cycle of 
addiction and learning first-hand the risks involved in methamphetamine use and 
addiction. 
  
Methamphetamine: The Rush to Crash (1997). Educates the viewer to the dangers of 
methamphetamine use through slick computer graphics and personal testimonies.  
 
Meth: A Snap Shot of an Ugly Drug (1997). The Drug Enforcement Administration 
explores the creation and increased usage of meth.  
 
The East Coast Meth-Challenge (1997). A teleconference that discusses the increase 
of meth and what is being done to try to stop the epidemic and educate individuals 
on the harmful effects of meth.  
 
The West Coast Meth-Challenge (1997). A teleconference hosted by Barry R. 
McCaffrey, Director Office of National Drug Control Policy, and moderated by Tim 
Koppel.  
 
The Meth Effect (1997). Illustrates how methamphetamines affect the brain and 
other body systems. Also discussed are the meth high, withdrawal, relapse, and 
recovery.  
 
Meth Madness Town Hall Meeting-Public Forum on Meth's Potential Deadly Effects 
(2001).  A public forum with 13 speakers discussing methamphetamines, held in 
Yakima, WA on October 23, 2001.  
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